concept

LPS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LPS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

37Connections
4Hypotheses
3Analyses
36Outgoing
1Incoming
1Experiments
3Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameLPS
Key Genes/ProteinsACSL4, BAX, BCL2, BDNF, C1Q, GFAP
Related DiseasesAlzheimer's disease, depression, major depressive disorder
Related Pathwaysautophagy, MAPK
Linked Hypotheses4 hypotheses

Wiki Pages (1)

Knowledge base pages for this entity

LLPS Modulator Therapy

therapeutic · 1296 words

Pathway Diagram

graph TD
    LPS["LPS"]
    LPS -->|"activates"| NF_kappaB["NF-kappaB"]
    LPS -->|"activates"| MAPK["MAPK"]
    LPS -->|"causes"| pulmonary_inflammation["pulmonary inflammation"]
    LPS -->|"causes"| neuroinflammation["neuroinflammation"]
    LPS -->|"causes"| Acute_Lung_Injury["Acute Lung Injury"]
    LPS -->|"activates"| NLRP3_Inflammasome_Activation["NLRP3 Inflammasome Activation"]
    LPS -->|"causes"| Septic_Cardiomyopathy["Septic Cardiomyopathy"]
    LPS -->|"upregulates"| C3["C3"]
    LOXL3["LOXL3"] -->|"modulates"| LPS

Outgoing (36)

TargetRelationTypeStr
C3upregulatesprotein0.90
GFAPactivatesprotein0.90
NLRP3 Inflammasome Activationactivatesprocess0.90
Septic Cardiomyopathycausesdisease0.90
MAPKactivatespathway0.90

Incoming (1)

SourceRelationTypeStr
LRRK2interacts_withgene0.60

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TLR4/MyD88/NF-κB Axis Blockade to Interrupt LPS-Mediated Gut 0.703 neurodegeneration How do gut microbiome-derived metabolite
LPS-primed microglial trained immunity establishes persisten 0.670 neurodegeneration Synaptic pruning by microglia in neurode
Intestinal Permeability Defects → Systemic LPS Translocation 0.630 neurodegeneration What are the mechanisms by which gut mic
Liquid-Liquid Phase Separation (LLPS) Saturation Partitionin 0.461 neurodegeneration What determines the spatial organization

Mentioning Analyses (3)

Scientific analyses that reference this entity

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.778

What determines the GPX4/ACSL4 balance that switches microglia from protective t

immunology | 2026-04-15 | 0 hypotheses

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.730

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism and inter clinical Alzheimer's Disease 0.400 0.50 human proposed $7,500,000

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (3)

Multi-agent debates referencing this entity

The study shows that G3BP1 ubiquitination inhibits LLPS in vitro, but the molecu

closed · Rounds: 4 · Score: 0.79 · 2026-04-21

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

closed · Rounds: 4 · Score: 0.84 · 2026-04-16

While ACSL4-driven ferroptosis was strongly supported, the molecular triggers th

closed · Rounds: 4 · Score: 0.80 · 2026-04-16

Related Research

Hypotheses and analyses mentioning LPS in their description or question text

No additional research found